Literature DB >> 33663419

Hyperthermia in a pediatric patient with neuroblastoma during anesthesia: a case report.

Chuan Wang1, Wenqiong Xin1, Yi Ji2.   

Abstract

BACKGROUND: Neuroblastoma is the most common malignant extracranial solid tumor in pediatrics patients. Intraoperative hyperthermia is extremely rare in patients with neuroblastoma and can cause a series of complications. Here, we represent a case of neuroblastoma accompanied by hyperthermia during anesthesia, and propose a rational explanation and management options. CASE
PRESENTATION: The patient had gait disturbance and sitting-related pain without fever. Magnetic resonance imaging revealed a soft tissue mass located in the right posterior mediastinum, paravertebral space and canalis vertebralis. Serum tumor marker screening showed that the patient had increased epinephrine, norepinephrine and neuron specific enolase levels, with an increased 24 hour urine vanillylmandelic acid level. Intraspinal tumor resection was conducted. The temperature of the patient rapidly arose to 40.1 °C over 10 minutes when waiting for tracheal extubation. The arterial gas analysis results indicated malignant hyperthermia was less likely, and dantrolene was not administered. Physical cooling methods were used, and the temperature dropped to 38.6 ℃. The trachea was successfully extubated. Histological results confirmed the diagnosis of neuroblastoma.
CONCLUSIONS: Hyperthermia during anesthesia is a serious adverse event. Catecholamines secreted from neuroblatoma cells can lead to hypermetabolism and hyperthermia. Surgeons and anesthesiologists should be aware of the possibility of hyperthermia in patients with neuroblastoma.

Entities:  

Keywords:  Catecholamine; Hyperthermia; Neuroblastoma

Mesh:

Year:  2021        PMID: 33663419      PMCID: PMC7934373          DOI: 10.1186/s12893-021-01124-3

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  9 in total

1.  Intraoperative hyperthermia in a child with neuroblastoma.

Authors:  James F Mayhew
Journal:  Paediatr Anaesth       Date:  2006-08       Impact factor: 2.556

Review 2.  Hemostasis and Thrombosis in Extreme Temperatures (Hypo- and Hyperthermia).

Authors:  Marcel Levi
Journal:  Semin Thromb Hemost       Date:  2018-06-19       Impact factor: 4.180

3.  Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.

Authors:  Xuebing Xu
Journal:  Med Hypotheses       Date:  2019-02-06       Impact factor: 1.538

4.  Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients.

Authors:  I R N Verly; R Leen; J R Meinsma; G K J Hooijer; C D Savci-Heijink; J van Nes; M Broekmans; R J A Wanders; A B P van Kuilenburg; G A M Tytgat
Journal:  Eur J Cancer       Date:  2019-02-22       Impact factor: 9.162

5.  Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes.

Authors:  G A Gronert; R A Theye
Journal:  Anesthesiology       Date:  1976-01       Impact factor: 7.892

6.  Cancer incidence among children and adolescents in the United States, 2001-2003.

Authors:  Jun Li; Trevor D Thompson; Jacqueline W Miller; Lori A Pollack; Sherri L Stewart
Journal:  Pediatrics       Date:  2008-06       Impact factor: 7.124

Review 7.  Update on neuroblastoma.

Authors:  Erika A Newman; Shahab Abdessalam; Jennifer H Aldrink; Mary Austin; Todd E Heaton; Jennifer Bruny; Peter Ehrlich; Roshni Dasgupta; Reto M Baertschiger; Timothy B Lautz; Daniel S Rhee; Max R Langham; Marcus M Malek; Rebecka L Meyers; Jaimie D Nathan; Brent R Weil; Stephanie Polites; Mary Beth Madonna
Journal:  J Pediatr Surg       Date:  2018-09-19       Impact factor: 2.545

Review 8.  The neurological and cognitive consequences of hyperthermia.

Authors:  Edward James Walter; Mike Carraretto
Journal:  Crit Care       Date:  2016-07-14       Impact factor: 9.097

9.  Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.

Authors:  Wen-Guang He; Yu Yan; Wen Tang; Rong Cai; Gang Ren
Journal:  Oncotarget       Date:  2017-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.